Introduction: Hepatic encephalopathy (HE) is prevalent and is associated with increased morbidity and mortality among patients with cirrhosis. On October 1, 2022, a new, specific International Classification of Diseases-10 code for HE, K76.82, was introduced. We aimed to analyze the diagnostic accuracy of K76.82.
Methods: Diagnostic performance of K76.82 for HE (sensitivity, specificity, positive predictive ratio, and negative predictive ratio) was evaluated in 2 large health systems compared with lactulose, rifaximin, and K72.90.
Results: A total of 2,483 patients were analyzed. The combination term "lactulose or rifaximin" showed the highest sensitivity of >98% while K76.82 demonstrated a specificity of >87% in all cohorts.
Discussion: Although K76.82 is promising, the combination term "lactulose or rifaximin" identified patients with HE more accurately.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.14309/ajg.0000000000002560 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!